ClinicalTrials.gg
Active, not recruitingNCT05520528Updated Jul 1, 2026

Impact of Group Participation on Adults With Aphasia

An interventional study of Language intervention with group sessions and independent tasks with emphasis on improving reading and writing skills among persons with aphasia in Aphasia, Acquired, Stroke and Rehabilitation, sponsored by University of Arkansas. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-01.

Sponsored by University of Arkansas · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the study is to examine the impact of group participation on adults with aphasia. Participants will complete a standard pre-and post-assessment of language abilities (speech, comprehension, reading, and/or writing). Then participants will attend 90-minute weekly reading group sessions during an academic semester.

Read the detailed description

The objective of this research is to determine if attendance in groups positively impacts language skills, activity/participation, and/or quality of life in persons with aphasia.

This study will employ a university-clinic based outpatient group to administer language intervention. The specific aims of this study are to determine if group participation improves (1) life participation as measured by self-report questionnaires, (2) intervention-specific language skills as measured by treatment-related measures (e.g., reading comprehension and written expression), and (3) performance on non-treated language test scores as measured by a language assessment battery.

Participants will complete 4-5 individual testing sessions (e.g., initial assessment and pre-/post-testing), 7-12 group sessions (90-minute weekly reading group session), and 7-12 independent sessions at home (e.g., completion of weekly reading assignments).

The participants will read through a designated book incrementally across multiple weeks. The activities completed during the group sessions will focus on improving reading comprehension and written expression skills. Participants will read assigned passages at home and during the group sessions. Participants will complete a Copy and Recall Treatment (CART) worksheet independently to facilitate improvements in writing keywords related to the reading materials. CART involves copying target words and progresses to writing words from recall (Beeson, et al.). Participants will complete a reading comprehension worksheet and engage in discussion regarding the assigned book chapter.

Reading comprehension and written expression data will be collected and analyzed to compare the pre-treatment baseline performance from the first treatment session to the post-treatment performance from the last treatment session. Pre-and post-testing scores will be analyzed to investigate the change in scores across the 2-time points to determine the relative effectiveness of book club participation for improving reading comprehension, written expression, and life participation.

02

Conditions studied

  • Aphasia, Acquired
  • Stroke
  • Rehabilitation
  • Language Disorder, Acquired
03

In context

Aphasia

338 studies on the registry are indexed under Aphasia; 95 are open to participants now.

This study's planned enrollment of 40 is above the median of 30 across 298 interventional studies indexed under Aphasia.

Browse Aphasia studies →

Lead sponsor

University of Arkansas is the lead sponsor of 399 studies on the registry; 38 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 34 (92%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Pre-morbid proficient speaker of English
  • Diagnosis of adult-onset aphasia
  • Vision and hearing sufficient to complete assessments

Exclusion criteria

Exclusion Criteria:

  • No history of childhood speech or language difficulties
  • No history of major psychiatric illness, cognitive impairment, or neurological disorders such as seizures
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Reading Group

    All participants in this group will receive language intervention within weekly group sessions and independent tasks with emphasis on improving reading and writing skills among persons with aphasia.

    Behavioral: Language intervention with group sessions and independent tasks with emphasis on improving reading and writing skills among persons with aphasia

Interventions

  • BehavioralLanguage intervention with group sessions and independent tasks with emphasis on improving reading and writing skills among persons with aphasia

    The participants will read through a designated book incrementally across multiple weeks at home and complete reading, writing, and discussion related to weekly readings in a group setting.

06

What researchers measure

Primary outcomes

  1. Reading Comprehension Battery for Aphasia-2 (RCBA-2; LaPointe & Horner, 1998) Scores

    To determine if group participation improves intervention-specific language skills in reading comprehension by comparing baseline score to 1-week post-intervention score

    Time frame: 1-week after intervention

Secondary outcomes

  1. Communication Confidence Rating Scale for Aphasia (CCRSA; Babbitt & Cherney, 2010)

    To determine participant's feelings related to their communication. Participants rate their confidence on a scale from 0 to 100 for different communication-related activities. Baseline score will be compared to 1-week post-intervention score

    Time frame: 1-week post-intervention

  2. Discourse Production Task

    Discourse analysis of participants producing monologic narratives (e.g., story retell, procedural explanation, picture sequence description, etc.). Baseline score will be compared to 1-week post-intervention score

    Time frame: 1-week post-intervention

  3. Patient Reported Outcomes Measurement Information System (PROMIS)

    Selected PROMIS instruments (from cognitive, emotional, and social domains) will be used to measure satisfaction with and quality of life. Baseline score will be compared to 1-week post-intervention score.

    Time frame: 1-week post-intervention

  4. Gray Oral Reading Test (GORT; Wiederholt & Bryant, 2012)

    To determine changes in oral reading and reading comprehension, baseline score will be compared to 1-week post-intervention score

    Time frame: 1-week post-intervention

  5. Writing of Untrained Control Words (non-standardized).

    Writing untrained words that will be matched for frequency, length, and complexity with the CART trained words to measure generalization. Baseline score will be compared to 1-week post-intervention score

    Time frame: 1-week post-intervention

07

Study locations

1 site
  • UAMS CHP Speech & Hearing Clinic
    Little Rock, Arkansas 72204, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05520528
Responsible party
Sponsor
First posted
Aug 30, 2022
Start date
Sep 6, 2022
Primary completion
Jul 31, 2028 (estimated)
Completion
Dec 15, 2028 (estimated)
Last update
Jul 1, 2026

Study contacts

Dana Moser, Ph.D
principal investigator · University of Arkansas

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion